Biotechnology Focus Podcast

Ahead of Biotechnology Focus radio are some of the highlights of the week. ImmunoBiochem is haloed with angel investors after completing a new round of financing. Biotalent Canada provides subsidy to fund more “green jobs” for young graduates. eSight named one of the best inventions in 2017 by giving the gift of sight. Zymeworks presents results of ongoing completed dose escalation phase 1 oncology study. Welcome to another episode of Biotechnology Focus radio. I am your host, Michelle Currie, here to give you a run-down of the top stories of Canada’s biotech scene. +++++ Our first story this week takes us to the heart of Toronto with ImmunoBiochem Corporation as it completes a new round of financing led by angel investors and the company’s founding investor. The corporation has expanded its operations and is now located at Johnson & Johnson, JLABS, in the centre of Toronto. The company is focused on solving tumour heterogeneity by targeting a class of proteins in the tumour microenvironment with antibody